Annual EBIT
-$3.90 B
-$13.51 B-140.65%
31 December 2023
Summary:
Moderna annual earnings before interest & taxes is currently -$3.90 billion, with the most recent change of -$13.51 billion (-140.65%) on 31 December 2023. During the last 3 years, it has fallen by -$3.14 billion (-411.66%). MRNA annual EBIT is now -129.36% below its all-time high of $13.53 billion.MRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$27.00 M
+$1.30 B+102.12%
30 September 2024
Summary:
Moderna quarterly earnings before interest & taxes is currently $27.00 million, with the most recent change of +$1.30 billion (+102.12%) on 30 September 2024. Over the past year, it has increased by +$1.98 billion (+101.39%). MRNA quarterly EBIT is now -99.50% below its all-time high of $5.41 billion, reached on 31 December 2021.MRNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$2.33 B
+$1.98 B+45.89%
30 September 2024
Summary:
Moderna TTM earnings before interest & taxes is currently -$2.33 billion, with the most recent change of +$1.98 billion (+45.89%) on 30 September 2024. Over the past year, it has dropped by -$14.00 million (-0.60%). MRNA TTM EBIT is now -114.32% below its all-time high of $16.27 billion, reached on 31 March 2022.MRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -140.7% | +101.4% | -0.6% |
| 3 y3 years | -411.7% | -99.2% | -130.7% |
| 5 y5 years | -923.8% | +122.2% | -342.8% |
MRNA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -129.4% | at low | -99.5% | +101.4% | -114.3% | +51.1% |
| 5 y | 5 years | -129.4% | at low | -99.5% | +101.4% | -114.3% | +51.1% |
| alltime | all time | -129.4% | at low | -99.5% | +101.4% | -114.3% | +51.1% |
Moderna EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $27.00 M(-102.1%) | -$2.33 B(-45.9%) |
| June 2024 | - | -$1.27 B(+9.8%) | -$4.30 B(-9.7%) |
| Mar 2024 | - | -$1.16 B(-1625.0%) | -$4.77 B(+22.1%) |
| Dec 2023 | -$3.90 B(-140.6%) | $76.00 M(-103.9%) | -$3.90 B(+68.6%) |
| Sept 2023 | - | -$1.95 B(+12.2%) | -$2.31 B(-369.8%) |
| June 2023 | - | -$1.74 B(+486.5%) | $858.00 M(-83.1%) |
| Mar 2023 | - | -$296.00 M(-117.8%) | $5.07 B(-47.2%) |
| Dec 2022 | $9.60 B(-27.8%) | $1.67 B(+35.9%) | $9.60 B(-28.0%) |
| Sept 2022 | - | $1.23 B(-50.6%) | $13.35 B(-14.9%) |
| June 2022 | - | $2.48 B(-41.5%) | $15.68 B(-3.6%) |
| Mar 2022 | - | $4.24 B(-21.7%) | $16.27 B(+22.4%) |
| Dec 2021 | $13.30 B(-1842.6%) | $5.41 B(+52.1%) | $13.30 B(+75.2%) |
| Sept 2021 | - | $3.56 B(+15.9%) | $7.59 B(+99.5%) |
| June 2021 | - | $3.07 B(+142.9%) | $3.81 B(+510.8%) |
| Mar 2021 | - | $1.26 B(-526.7%) | $623.00 M(-181.7%) |
| Dec 2020 | -$763.00 M(+39.7%) | -$296.00 M(+28.7%) | -$763.00 M(+21.7%) |
| Sept 2020 | - | -$230.00 M(+101.8%) | -$626.70 M(+20.9%) |
| June 2020 | - | -$114.00 M(-7.3%) | -$518.43 M(-3.6%) |
| Mar 2020 | - | -$123.00 M(-23.0%) | -$537.93 M(-1.5%) |
| Dec 2019 | -$546.00 M(+43.2%) | -$159.70 M(+31.2%) | -$546.00 M(+3.8%) |
| Sept 2019 | - | -$121.74 M(-8.8%) | -$526.03 M(+8.9%) |
| June 2019 | - | -$133.50 M(+1.9%) | -$483.11 M(+9.8%) |
| Mar 2019 | - | -$131.07 M(-6.2%) | -$440.03 M(+15.4%) |
| Dec 2018 | -$381.31 M(+49.0%) | -$139.73 M(+77.3%) | -$381.31 M(+41.3%) |
| Sept 2018 | - | -$78.81 M(-12.8%) | -$269.92 M(+40.5%) |
| June 2018 | - | -$90.42 M(+25.0%) | -$192.05 M(+86.8%) |
| Mar 2018 | - | -$72.35 M(+155.3%) | -$102.79 M(+226.2%) |
| Dec 2017 | -$255.86 M(+14.3%) | -$28.34 M(+2889.3%) | -$31.51 M(+759.4%) |
| Sept 2017 | - | -$947.90 K(-18.0%) | -$3.67 M(+30.2%) |
| June 2017 | - | -$1.16 M(+8.0%) | -$2.82 M(+57.4%) |
| Mar 2017 | - | -$1.07 M(+117.3%) | -$1.79 M(+114.8%) |
| Dec 2016 | -$223.77 M(-6803.7%) | - | - |
| Dec 2016 | - | -$492.50 K(+404.1%) | -$832.80 K(-113.1%) |
| Sept 2016 | - | -$97.70 K(-23.9%) | $6.37 M(+17.2%) |
| June 2016 | - | -$128.40 K(+12.4%) | $5.43 M(+19.7%) |
| Mar 2016 | - | -$114.20 K(-101.7%) | $4.54 M(+36.0%) |
| Dec 2015 | $3.34 M(-161.0%) | $6.71 M(-749.9%) | $3.34 M(+37.2%) |
| Sept 2015 | - | -$1.03 M(+1.0%) | $2.43 M(-166.5%) |
| June 2015 | - | -$1.02 M(-22.3%) | -$3.66 M(-384.7%) |
| Mar 2015 | - | -$1.31 M(-122.7%) | $1.28 M(-123.5%) |
| Dec 2014 | -$5.47 M(+302.0%) | $5.80 M(-181.5%) | -$5.47 M(-58.6%) |
| Sept 2014 | - | -$7.12 M(-281.7%) | -$13.21 M(+88.7%) |
| June 2014 | - | $3.92 M(-148.6%) | -$7.00 M(-37.0%) |
| Mar 2014 | - | -$8.07 M(+316.0%) | -$11.11 M(+593.0%) |
| Dec 2013 | -$1.36 M(-82.5%) | -$1.94 M(+112.7%) | -$1.60 M(-63.8%) |
| Sept 2013 | - | -$912.00 K(+390.3%) | -$4.43 M(-12.6%) |
| June 2013 | - | -$186.00 K(-113.0%) | -$5.06 M(+107.0%) |
| Mar 2013 | - | $1.44 M(-130.1%) | -$2.45 M(-68.6%) |
| Dec 2012 | -$7.79 M(-72.5%) | -$4.76 M(+207.5%) | -$7.79 M(-60.4%) |
| Sept 2012 | - | -$1.55 M(-163.7%) | -$19.67 M(-12.6%) |
| June 2012 | - | $2.43 M(-162.2%) | -$22.51 M(-25.8%) |
| Mar 2012 | - | -$3.91 M(-76.5%) | -$30.33 M(-3.6%) |
| Dec 2011 | -$28.28 M(+13.5%) | -$16.64 M(+279.4%) | -$31.46 M(+61.4%) |
| Sept 2011 | - | -$4.39 M(-18.6%) | -$19.50 M(-15.6%) |
| June 2011 | - | -$5.39 M(+7.0%) | -$23.09 M(+8.6%) |
| Mar 2011 | - | -$5.04 M(+7.7%) | -$21.25 M(-4.2%) |
| Dec 2010 | -$24.93 M(+143.5%) | -$4.68 M(-41.4%) | -$22.19 M(+6.7%) |
| Sept 2010 | - | -$7.98 M(+124.3%) | -$20.80 M(+4.9%) |
| June 2010 | - | -$3.56 M(-40.5%) | -$19.83 M(-16.1%) |
| Mar 2010 | - | -$5.97 M(+81.7%) | -$23.64 M(+142.8%) |
| Dec 2009 | -$10.24 M | -$3.29 M(-53.1%) | -$9.73 M(-47.4%) |
| Sept 2009 | - | -$7.01 M(-4.8%) | -$18.50 M(-13.0%) |
| June 2009 | - | -$7.36 M(-192.9%) | -$21.26 M(-24.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $7.93 M(-165.8%) | -$28.13 M(-44.5%) |
| Dec 2008 | -$50.69 M(-7.1%) | -$12.05 M(+23.2%) | -$50.69 M(-0.5%) |
| Sept 2008 | - | -$9.78 M(-31.3%) | -$50.95 M(-12.4%) |
| June 2008 | - | -$14.23 M(-2.7%) | -$58.13 M(+2.1%) |
| Mar 2008 | - | -$14.63 M(+18.8%) | -$56.93 M(+4.4%) |
| Dec 2007 | -$54.53 M(+86.0%) | -$12.31 M(-27.4%) | -$54.53 M(+2.3%) |
| Sept 2007 | - | -$16.97 M(+30.2%) | -$53.32 M(+19.1%) |
| June 2007 | - | -$13.03 M(+6.6%) | -$44.75 M(+36.1%) |
| Mar 2007 | - | -$12.23 M(+10.2%) | -$32.88 M(+12.1%) |
| Dec 2006 | -$29.32 M(-13.3%) | -$11.10 M(+32.2%) | -$29.32 M(+5.8%) |
| Sept 2006 | - | -$8.40 M(+628.4%) | -$27.70 M(-2.9%) |
| June 2006 | - | -$1.15 M(-86.7%) | -$28.55 M(-20.9%) |
| Mar 2006 | - | -$8.67 M(-8.6%) | -$36.08 M(+6.8%) |
| Dec 2005 | -$33.80 M(+18.6%) | -$9.48 M(+2.7%) | -$33.80 M(+11.8%) |
| Sept 2005 | - | -$9.24 M(+6.3%) | -$30.24 M(+6.0%) |
| June 2005 | - | -$8.69 M(+36.1%) | -$28.52 M(+4.6%) |
| Mar 2005 | - | -$6.39 M(+7.9%) | -$27.27 M(-4.3%) |
| Dec 2004 | -$28.49 M(+358.7%) | -$5.92 M(-21.3%) | -$28.49 M(-0.0%) |
| Sept 2004 | - | -$7.53 M(+1.2%) | -$28.50 M(+4.7%) |
| June 2004 | - | -$7.44 M(-2.1%) | -$27.22 M(+147.9%) |
| Mar 2004 | - | -$7.60 M(+28.1%) | -$10.98 M(+76.8%) |
| Dec 2003 | -$6.21 M(-52.2%) | -$5.93 M(-5.0%) | -$6.21 M(+15.5%) |
| Sept 2003 | - | -$6.25 M(-171.0%) | -$5.38 M(+106.1%) |
| June 2003 | - | $8.80 M(-410.7%) | -$2.61 M(-79.9%) |
| Mar 2003 | - | -$2.83 M(-44.5%) | -$12.96 M(-0.2%) |
| Dec 2002 | -$12.99 M(+36.0%) | -$5.10 M(+46.6%) | -$12.99 M(+18.3%) |
| Sept 2002 | - | -$3.48 M(+124.1%) | -$10.98 M(+16.9%) |
| June 2002 | - | -$1.55 M(-45.8%) | -$9.40 M(-6.1%) |
| Mar 2002 | - | -$2.86 M(-7.4%) | -$10.01 M(+4.8%) |
| Dec 2001 | -$9.55 M(-7.6%) | -$3.09 M(+63.2%) | -$9.55 M(-5.9%) |
| Sept 2001 | - | -$1.89 M(-12.4%) | -$10.15 M(+0.5%) |
| June 2001 | - | -$2.16 M(-10.0%) | -$10.11 M(-2.5%) |
| Mar 2001 | - | -$2.40 M(-35.0%) | -$10.36 M(+0.3%) |
| Dec 2000 | -$10.34 M(+9.3%) | -$3.69 M(+99.9%) | -$10.34 M(-2.4%) |
| Sept 2000 | - | -$1.85 M(-23.5%) | -$10.59 M(-1.1%) |
| June 2000 | - | -$2.42 M(+1.8%) | -$10.71 M(+7.2%) |
| Mar 2000 | - | -$2.38 M(-39.9%) | -$9.99 M(-0.2%) |
| Dec 1999 | -$9.45 M(+301.9%) | -$3.95 M(+101.5%) | -$10.02 M(+17.6%) |
| Sept 1999 | - | -$1.96 M(+15.4%) | -$8.51 M(+24.3%) |
| June 1999 | - | -$1.70 M(-29.2%) | -$6.85 M(+28.0%) |
| Mar 1999 | - | -$2.40 M(-2.1%) | -$5.35 M(+69.8%) |
| Dec 1998 | -$2.35 M(-60.8%) | -$2.45 M(+717.3%) | -$3.15 M(+1.7%) |
| Sept 1998 | - | -$300.00 K(+50.0%) | -$3.10 M(-31.1%) |
| June 1998 | - | -$200.00 K(0.0%) | -$4.50 M(-19.6%) |
| Mar 1998 | - | -$200.00 K(-91.7%) | -$5.60 M(-8.2%) |
| Dec 1997 | -$6.00 M(+1100.0%) | -$2.40 M(+41.2%) | -$6.10 M(+64.9%) |
| Sept 1997 | - | -$1.70 M(+30.8%) | -$3.70 M(+85.0%) |
| June 1997 | - | -$1.30 M(+85.7%) | -$2.00 M(+300.0%) |
| Mar 1997 | - | -$700.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) |
| Dec 1996 | -$500.00 K(+400.0%) | - | - |
| Sept 1996 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| June 1996 | -$100.00 K(0.0%) | $200.00 K(+100.0%) | -$100.00 K(-66.7%) |
| Mar 1996 | - | $100.00 K(-133.3%) | -$300.00 K(-25.0%) |
| Dec 1995 | - | -$300.00 K(+200.0%) | -$400.00 K(+100.0%) |
| Sept 1995 | - | -$100.00 K(<-9900.0%) | -$200.00 K(<-9900.0%) |
| June 1995 | -$100.00 K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(-100.0%) | $100.00 K(>+9900.0%) |
| Dec 1994 | - | -$100.00 K(-200.0%) | $0.00(-100.0%) |
| Sept 1994 | - | $100.00 K(0.0%) | $200.00 K(0.0%) |
| June 1994 | $200.00 K | $100.00 K(-200.0%) | $200.00 K(+100.0%) |
| Mar 1994 | - | -$100.00 K(-200.0%) | $100.00 K(-50.0%) |
| Dec 1993 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Sept 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Moderna annual earnings before interest & taxes?
- What is the all time high annual EBIT for Moderna?
- What is Moderna annual EBIT year-on-year change?
- What is Moderna quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Moderna?
- What is Moderna quarterly EBIT year-on-year change?
- What is Moderna TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Moderna?
- What is Moderna TTM EBIT year-on-year change?
What is Moderna annual earnings before interest & taxes?
The current annual EBIT of MRNA is -$3.90 B
What is the all time high annual EBIT for Moderna?
Moderna all-time high annual earnings before interest & taxes is $13.53 B
What is Moderna annual EBIT year-on-year change?
Over the past year, MRNA annual earnings before interest & taxes has changed by -$13.51 B (-140.65%)
What is Moderna quarterly earnings before interest & taxes?
The current quarterly EBIT of MRNA is $27.00 M
What is the all time high quarterly EBIT for Moderna?
Moderna all-time high quarterly earnings before interest & taxes is $5.41 B
What is Moderna quarterly EBIT year-on-year change?
Over the past year, MRNA quarterly earnings before interest & taxes has changed by +$1.98 B (+101.39%)
What is Moderna TTM earnings before interest & taxes?
The current TTM EBIT of MRNA is -$2.33 B
What is the all time high TTM EBIT for Moderna?
Moderna all-time high TTM earnings before interest & taxes is $16.27 B
What is Moderna TTM EBIT year-on-year change?
Over the past year, MRNA TTM earnings before interest & taxes has changed by -$14.00 M (-0.60%)